Avrum Z. Bluming, MD, an expert on hormone replacement therapy, debunks the menopause misconceptions that keep women from ...
Doctors at Danat Al Emarat Hospital are using cryopreservation, a technique that involves the freezing and storing of ovarian tissue over a time period of the patient's choosing, which can then be ...
Feburary "Wear Red Day", a day focused on raising awareness for heart disease in women.Dr. Arasi Maran, an associate ...
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
February is American Heart Month, a highlight of which is Wear Red Day, which aims to raise awareness about heart disease in ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...
Mayo Clinic, Mount Sinai and Huntsman Cancer Insitute are delivering services from chemotherapy to imaging in cancer patients ...
Argentina's presidential office said on Wednesday that President Javier Milei had taken the decision to ban gender change ...
The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...
One of the UK’s most senior radiotherapy experts has spoken publicly for the first time about living with incurable cancer.
The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.